News

You are here

Knowledge for Growth
Novosanis is teaming up with Voxdale at KfG2018! We are excited to share our research data and showcase our medical device platforms, VAX-ID™ and Colli-Pee™. See you there!
World Health Day 2018
April 7th marks World Health Day
Novosanis will present its VAX-ID™ device platform during BioJapan
Prostate cancer is the most common male cancer, with around 400,000 new cases every year in Europe.
For a healthy life
Urology week is an initiative from the European Association for Urology (EAU) that tries to raise awareness for urological care and its importance in improving quality of life.
Novosanis is proud to announce that as from today its quality system is certified as compliant with the requirements of ISO13485 quality standards for manufacturers of medical devices.
The European Commission granted a “Seal of Excellence” to Novosanis’ project proposal UROSCREEN on the use of Colli-Pee in cervical screening programs.
The European Commission granted a “Seal of Excellence” to Novosanis’ project proposal UROSCREEN on the use of Colli-Pee in cervical screening programs.

Pages